Human approach is hypothesized to be superior to technology for supportive cancer care according to new data in JNCCN
Researchers found that utilizing a team-based approach with trained health educators helped to improve patient care and lower long-term costs
2025-11-10
(Press-News.org) PLYMOUTH MEETING, PA [November 10, 2025] — New research in the November 2025 issue of JNCCN—Journal of the National Comprehensive Cancer Network explores the perceptions regarding the effectiveness of team-based and technology-based approaches for supportive care for people with cancer. The ongoing supportive care study includes discussions on patient goals, values, and preferences, in addition to symptom management. According to the results from this mixed-methods study, 87.5% of team-based clinic participants perceived that method is more likely to improve patient care, versus 25% of the technology-based clinic participants.
The cluster-randomized trial involves 26 different cancer clinics, ranging from academic to community, veterans’ affairs, and safety net. The team-based approach relies on community health workers or peer support while the technology version focuses on electronic medical records. In this study, the teams involved in the trial were thoroughly trained on their assigned type of interventions. Over the course of the study, they shared their thoughts via a 71-question online survey plus one-on-one interviews.
“The broad support for team-based models using community health workers was surprising, given the increasing reliance on technology to deliver supportive cancer care," stated senior author Manali Patel, MD, MPH, MS, Stanford Cancer Institute. "Most of the participants believed that peer support models would be most effective and many noted that prioritizing and funding this work is crucial to ensure that all patients receive supportive care."
Dr. Patel also noted that "studies show when people have appropriate symptom control and have discussions regarding their goals, values, and preferences for care, there are long-term cost savings. Proactive approaches to address symptoms and discuss patient goals can reduce unnecessary and unwanted hospital visits down the line."
Notably, only 31.3% of respondents felt their center had the financial resources to sustain and build on the team-based supportive care, with 37.5% feeling adequately resourced for growing the technology-based approach beyond the boundaries of the study. However, most agreed that their organization’s leadership was open to adapting care processes, with 75% in the team-based group and 62.5% of the tech-based group saying their leadership was receptive to change.
“This study suggests that in supportive cancer care, technology alone may not be the answer to effective symptom management and advance care planning,” commented Loretta Erhunmwunsee, MD, FACS, Vice President, Chief Health Access and Community Enrichment Officer for City of Hope, who was not involved in this study.
Dr. Erhunmwunsee, who previously helped lead an NCCN Working Group on Measuring And Addressing Health-Related Social Needs in Cancer continued: “The greatest impact will come from technology embedded within strong, equity-driven, team-based systems that center the patient experience. We must therefore design digital innovations that strengthen relationships, continuity, and equity across the care journey. Perhaps the path forward is not team versus tech, but rather both—guided by equity.”
To read the entire study “Team-Based Versus Technology-Based Supportive Cancer Care: A Mixed Methods Study of Multi-Site Implementation,” and view all of the survey responses, visit JNCCN.org.
# # #
About JNCCN—Journal of the National Comprehensive Cancer Network
More than 25,000 oncologists and other cancer care professionals across the United States read JNCCN—Journal of the National Comprehensive Cancer Network. This peer-reviewed, indexed medical journal provides the latest information about innovation in translational medicine, and scientific studies related to oncology health services research, including quality care and value, bioethics, comparative and cost effectiveness, public policy, and interventional research on supportive care and survivorship. JNCCN features updates on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), review articles elaborating on guidelines recommendations, health services research, and case reports highlighting molecular insights in patient care. JNCCN is published by Harborside/BroadcastMed. Visit JNCCN.org for more information.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is marking 30 years as a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to defining and advancing quality, effective, equitable, and accessible cancer care and prevention so all people can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus-driven recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-11-10
New York, NY (November 10 2025) — In a high honor, Jean-Frédéric Colombel, MD, a leading inflammatory bowel disease (IBD) expert at the Icahn School of Medicine at Mount Sinai, will deliver the 31st Anatomy Lesson on Thursday, November 20, at the Concertgebouw in Amsterdam. His lecture, “Tackling the Growing Problem of Immune Diseases—Crohn’s Disease as an Example,” will explore Mount Sinai’s pioneering work in the early detection, prevention, and treatment of IBD.
The Anatomy Lesson, an annual public lecture organized by Amsterdam UMC, invites leading international physicians and researchers to reflect on medicine’s ...
2025-11-10
When researchers look for potential cancer therapy targets, they typically go after protein-coding genes that participate in disease progression. Disrupt them and negate whatever role they play in cancer’s development or spread. Researchers at Cold Spring Harbor Laboratory (CSHL) have also been working on another kind of target. They’re studying a long non-coding RNA called MALAT1. So far, it’s been linked to more than 20 different types of tumors.
In a new and unique study published in Molecular Therapy: Oncology, CSHL researchers track MALAT1 levels ...
2025-11-10
ORLANDO (NOV. 9, 2025) – Allergist Cherie Zachary, MD, of Bloomington, MN was installed as president of the American College of Allergy, Asthma and Immunology (ACAAI) at the ACAAI Annual Scientific Meeting on November 10 in Orlando. Allergist David Stukus, MD, of Columbus, OH, was elected ACAAI president-elect.
Other newly-elected ACAAI officers are Maureen Petersen, MD, of Clayton, NC, as vice president and Melinda Rathkopf, MD, MBA, of Atlanta, GA, as treasurer. Regents elected for three-year terms include Christopher C. Chang, MD, PhD, MBA, Hollywood, Florida, Mitchell H. Grayson, MD, Columbus, OH, and Jay A. Lieberman, ...
2025-11-10
More than 99% of the world’s 7.7 billion people have one or more of their environmental rights threatened, according to new research.
In the most comprehensive analysis of inequality in environmental conditions to date, CU Boulder researchers revealed that nearly half of the global population lives in regions facing three or more environmental problems. Those include polluted air, unsafe water, extreme heat, food insecurity and biodiversity loss.
The analysis was published September 25 in Environmental Research Communications.
It provides strong ...
2025-11-10
A hormone produced in the thyroid gland can play a key role in the development of prostate cancer. This is shown in a new study by an international research group led by Umeå University, Sweden, and the Medical University of Vienna, Austria. By blocking a receptor for the hormone, the growth of tumour cells in the prostate was inhibited. In the long term, the discovery may open up a new way of attacking certain types of aggressive prostate cancer.
"The results indicate that the receptor in question is a driving force in the growth of cancer. Substances that block it could thus be a target for future drugs against prostate cancer," ...
2025-11-10
New Curtin University research has found invasive cane toads are on track to reach Western Australia’s Pilbara region within the next 10 to 20 years, threatening to cause widespread losses among native species and significant cultural and economic harm.
The study, published in Scientific Reports, predicts that without containment efforts, the toxic amphibians will colonise up to 75 per cent of the Pilbara within three decades, putting 25 native species at risk of serious population declines. These include several species of native marsupial predators like northern quolls, ghost bat and kaluta, as well as frog-eating snakes, blue-tongue skinks and goannas.
Of ...
2025-11-10
As world leaders begin COP30 climate negotiations in Brazil this week, an international team co-led by a University of Sydney researcher has warned of a hidden crisis undermining global biodiversity and carbon targets: the quiet abandonment of conservation projects.
The comment paper, ‘Conservation abandonment is a policy blind spot’, published in Nature Ecology & Evolution, was co-led by Dr Matthew Clark, a postdoctoral researcher in the Thriving Oceans Research Hub at the University of Sydney and an honorary research associate in the Centre for Environmental Policy at Imperial College ...
2025-11-10
Iron deficiency is globally widespread. Women are particularly affected, with one in five in Europe suffering from iron deficiency. The consequences are anaemia, constant fatigue, chronic headaches and a weakened immune system. Researchers led by ETH professor Raffaele Mezzenga have now developed a new dietary supplement that could efficiently treat iron deficiency and anaemia. This development is being co-led by Michael B. Zimmermann, professor emeritus at ETH Zurich. The preparation consists of edible oat protein ...
2025-11-10
Understanding the properties of different materials is an important step in material design. X-ray absorption spectroscopy (XAS) is an important technique for this, as it reveals detailed insights about a material’s composition, structure, and functional characteristics. The technique works by directing a beam of high-energy X-rays at a sample and recording how X-rays of different energy levels are absorbed. Similar to how white light splits into a rainbow after passing through a prism, XAS produces a spectrum of X-rays with different energies. This spectrum is called as spectral data, which acts like an unique fingerprint of a material, ...
2025-11-10
Portable genetic sequencers used around the world to sequence DNA have critical, previously unreported security vulnerabilities that could reveal or alter genetic information without detection, according to a new study.
Researchers from the University of Florida have, for the first time, exposed these security risks in devices from Oxford Nanopore Technologies, which produces nearly all the portable genetic sequencers in the world.
Alerted by the security researchers, Oxford Nanopore Technologies has rolled out updated software to patch the vulnerabilities. But out-of-date software, or unsecured internet systems, could still leave some DNA sequencers vulnerable ...
LAST 30 PRESS RELEASES:
[Press-News.org] Human approach is hypothesized to be superior to technology for supportive cancer care according to new data in JNCCN
Researchers found that utilizing a team-based approach with trained health educators helped to improve patient care and lower long-term costs
